[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.52.237. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News and Perspectives
April 2, 2003

CDC Resource Focuses on DES Exposure

JAMA. 2003;289(13):1624. doi:10.1001/jama.289.13.1624

A comprehensive information resource about exposure to diethylstilbestrol (DES) is now available on the Internet for clinicians, consumers, and others (http://www.cdc.gov/DES). The resource, "DES Update," was launched in March by the Centers for Disease Control and Prevention (CDC).

DES is a synthetic estrogen first prescribed in 1938 for women who experienced miscarriages or premature deliveries. Prescriptions for pregnant women were banned in 1971 by the Food and Drug Administration after research linked DES to a rare vaginal cancer, clear cell adenocarcinoma, in female offspring (N Engl J Med. 1971;284:878-881).

First Page Preview View Large
First page PDF preview
First page PDF preview
×